Abpro Bio Co., Ltd. (KOSDAQ:195990)
286.00
-2.00 (-0.69%)
Last updated: Jun 26, 2025
Abpro Bio Revenue
Abpro Bio had revenue of 8.87B KRW in the quarter ending March 31, 2025, with 45.31% growth. This brings the company's revenue in the last twelve months to 34.43B, up 47.60% year-over-year. In the year 2024, Abpro Bio had annual revenue of 31.66B with 24.78% growth.
Revenue (ttm)
34.43B
Revenue Growth
+47.60%
P/S Ratio
2.42
Revenue / Employee
765.10M
Employees
45
Market Cap
83.41B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 31.66B | 6.29B | 24.78% |
Dec 31, 2023 | 25.38B | 3.26B | 14.76% |
Dec 31, 2022 | 22.11B | -10.80B | -32.82% |
Dec 31, 2021 | 32.91B | -2.88B | -8.05% |
Dec 31, 2020 | 35.80B | 3.87B | 12.11% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.10T |
SK hynix | 71.40T |
Samsung Biologics | 4,898.69B |
LG Energy Solution | 25.76T |
Hyundai Motor Company | 178.98T |
Doosan Enerbility | 15.88T |
Hanwha Aerospace | 15.28T |
KB Financial Group | 14.93T |